ImmunoIVD

ImmunoIVD develops and manufactures IVD kits for newborn screening, enabling detection of conditions such as Severe Combined Immunodeficiency (SCID) and Spinal Muscular Atrophy (SMA) within national and regional programs.

They specialize in qPCR assays purpose-built for newborn screening laboratories—easy to use, cost-effective, and optimized for high-throughput workflows.

With a strong focus on quality and customer support, the company supply newborn screening programs across Europe, including Sweden, and internationally, reaching as far as New Zealand. ImmunoIVD is located in Nacka Strand and was founded in 2015.